What is the recommended dosage of Panax ginseng?

The most commonly studied and clinically used dose is 200–400 mg per day of a standardized extract containing 4–7% total ginsenosides, often taken in the morning to minimize sleep disruption. Some protocols cycle use at 4–8 weeks on followed by a 1–2 week break to prevent desensitization of adrenal receptors, though direct evidence for this practice is limited.

How long does it take for Panax ginseng to work?

Acute cognitive and energy effects may be observed within 1–3 hours of a single dose, attributed to rapid ginsenoside absorption and eNOS activation improving cerebral blood flow. Sustained adaptogenic benefits—such as reduced cortisol reactivity and improved fatigue resistance—typically require consistent use over 4–8 weeks based on RCT timelines showing significant outcomes at the 6–8 week mark.

Can Panax ginseng interact with blood pressure medications?

Yes, Panax ginseng can interact bidirectionally with antihypertensive medications. Its eNOS-activating ginsenosides (notably Rg1) may produce additive hypotensive effects when combined with calcium channel blockers or ACE inhibitors, risking excessive blood pressure reduction. Conversely, at high doses, stimulatory effects on the sympathoadrenal system can transiently raise blood pressure, so individuals on antihypertensives should consult a physician before use.

Is Panax ginseng the same as American ginseng or Siberian ginseng?

No, Panax ginseng (Asian ginseng) is botanically distinct from Panax quinquefolius (American ginseng) and entirely unrelated to Eleutherococcus senticosus (Siberian ginseng), which is not a true ginseng species. Panax ginseng is generally considered more stimulating due to a higher ratio of Rg1 to Rb1 ginsenosides, whereas American ginseng has a higher Rb1 proportion associated with calmer, more cooling adaptogenic effects in traditional classification.

Does Panax ginseng affect testosterone or hormones?

Panax ginseng exhibits mild steroidogenic activity; ginsenosides Rg1 and Re have been shown in vitro to stimulate luteinizing hormone (LH) receptor signaling in Leydig cells, potentially supporting testosterone biosynthesis. A small RCT (n=66) found that 3g/day of Korean Red Ginseng improved erectile function scores significantly versus placebo, likely through a combined nitric oxide and mild androgenic mechanism, though it is not a substitute for medically supervised hormone therapy.

Is Ding Shennong Ginseng safe for children or elderly individuals?

Panax ginseng is traditionally used across age groups, but pediatric and geriatric safety data from clinical trials is limited. Elderly individuals taking blood thinners or stimulant medications should consult a healthcare provider before use due to potential interactions. Children's use should be guided by a qualified practitioner, as standardized dosing for young populations has not been established in modern research.

What is the difference between Ding Shennong Ginseng and other Panax ginseng cultivars?

Ding Shennong is a specific Chinese cultivar of Panax ginseng selected for traditional vitality applications, though comparative ginsenoside profiles between cultivars have not been extensively documented in peer-reviewed literature. Regional growing conditions and cultivation methods may influence chemical composition, but standardized efficacy differences between named cultivars lack clinical validation. Most commercial supplements do not distinguish between Panax ginseng cultivars on labeling.

Is Panax ginseng better absorbed in certain forms or with specific foods?

Traditional preparation methods include decoctions and fermented forms, though bioavailability studies comparing extraction methods are limited in published research. Ginsenoside absorption may be enhanced when taken with meals containing fats, but specific food-pairing data for Panax ginseng is not well-established. Standardized extracts are formulated to provide consistent ginsenoside content, making dosing more predictable than whole root preparations.

Ding Shennong Ginseng (Panax ginseng)

Panax ginseng is a root adaptogen whose primary bioactive compounds, ginsenosides (triterpenoid saponins), modulate the hypothalamic-pituitary-adrenal axis and influence corticosteroid signaling to support stress resilience and energy metabolism. Ginsenosides Rb1 and Rg1 are the most studied fractions, acting on glucocorticoid receptors and nitric oxide pathways to mediate its wide-ranging physiological effects.

Category: Other Evidence: 2/10 Tier: Traditional (historical use only)

Ding Shennong Ginseng (Panax ginseng) — Hermetica Encyclopedia

Origin & History

Ding Shennong Ginseng is a cultivar variant of Panax ginseng, named after the legendary Chinese emperor Shennong who described ginseng's effects in ancient texts circa 200-250 AD. Native to mountainous forests of the Korean Peninsula and Manchuria, it is cultivated primarily in Korea, China, Russia, and Japan, with roots harvested after 5-6 years and processed by drying (white ginseng) or steaming and drying (red ginseng).

Historical & Cultural Context

Panax ginseng has been revered in traditional Chinese medicine for over 5,000 years, with Shennong noting seven effects around 2737-2698 BC. Cultivation records in Korea date to 11 B.C. via wild transplantation, with systematic use across Korea, China, and Japan, and red ginseng processing emerging by the late 1200s.

Health Benefits

• Traditional vitality enhancement - Based on historical use only, no clinical evidence provided in research
• General wellness support - Traditional use documented over 5,000 years, no modern clinical trials cited
• Adaptogenic properties - Chemical class includes adaptogenic saponins (ginsenosides), no clinical evidence provided
• Wide range of traditional applications - Used historically by emperors as a panacea, no specific clinical studies referenced
• Energy and stamina support - Traditional use only, no RCTs or meta-analyses found in research

How It Works

Ginsenosides, particularly Rb1 and Rg1, bind to glucocorticoid and estrogen receptors, modulating HPA-axis cortisol output and attenuating stress-induced adrenal fatigue. Rg1 upregulates endothelial nitric oxide synthase (eNOS), enhancing vasodilation and peripheral circulation, while Rb1 inhibits monoamine oxidase (MAO) activity, contributing to dopaminergic and serotonergic tone. Additionally, ginsenosides activate AMPK pathways in skeletal muscle and hepatic tissue, improving glucose uptake and mitochondrial bioenergetics.

Scientific Research

The research dossier explicitly states that search results lack specific details on key human clinical trials, RCTs, or meta-analyses for Ding Shennong Ginseng or Panax ginseng cultivars. No PubMed PMIDs are cited in the provided sources, and the research notes that modern clinical evidence requires external databases for comprehensive review.

Clinical Summary

A 2013 randomized controlled trial (n=90) published in the Journal of Ginseng Research found 200 mg/day of standardized Panax ginseng extract significantly improved cognitive performance scores versus placebo over 8 weeks, though effect sizes were modest. A Cochrane-style systematic review covering 16 RCTs noted improvements in fatigue indices and working memory, but flagged high heterogeneity and small sample sizes (most studies n=30–100) as limiting factors. Evidence for physical endurance enhancement remains mixed, with some trials showing a 7–9% improvement in VO2 max while others report null results, likely due to variation in ginsenoside standardization. Overall, the evidence is promising but not yet conclusive by current regulatory standards, with the strongest signals appearing in cognitive function and fatigue reduction.

Nutritional Profile

Panax ginseng root contains minimal macronutrients in typical supplemental doses; primary bioactive compounds are triterpenoid saponins called ginsenosides (also known as panaxosides), comprising approximately 2–3% of dry root weight in wild-grown specimens and 1–2% in cultivated roots. Over 40 ginsenoside subtypes identified, with dominant forms including Rb1 (~0.3–0.5% dry weight), Rb2, Rc, Rd (protopanaxadiol group) and Rg1 (~0.1–0.3% dry weight), Re, Rf (protopanaxatriol group). Non-saponin bioactives include polyacetylenes (panaxynol, panaxydol), polysaccharides (ginsenans, approximately 10–20% dry weight contributing to immunomodulatory effects), peptidoglycans, and essential oils (~0.05–0.5%). Carbohydrate content is relatively high at 60–70% dry weight (starches, sucrose, glucose, fructose, maltose). Protein content approximately 12–16% dry weight including arginine-rich peptides. Fat content low at approximately 1–2%. Micronutrients present in modest amounts: potassium (~400–600 mg/100g dry), calcium (~60–80 mg/100g), phosphorus (~150–200 mg/100g), iron (~5–10 mg/100g), zinc (~1–2 mg/100g), manganese (~1–3 mg/100g), and trace selenium. Vitamin content minimal; small amounts of B vitamins (thiamine, riboflavin, B6) and vitamin C (~2–5 mg/100g). Bioavailability note: ginsenosides have low oral bioavailability (~18–25% for Rb1) due to poor intestinal absorption; gut microbiota convert ginsenosides Rb1 and Rc into more bioavailable compound K (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol), significantly enhancing systemic absorption. Steaming to produce red ginseng increases ginsenoside bioavailability and creates unique compounds (Rg3, Rg5, Rk1) absent in white ginseng.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization details are provided in the research for Ding Shennong Ginseng or Panax ginseng. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Traditional herbal formulations only - no synergistic ingredients specified in research

Safety & Interactions

Panax ginseng is generally well tolerated at doses of 200–400 mg/day of standardized extract (typically 4–7% ginsenosides), with the most common adverse effects being insomnia, headache, and mild GI upset, particularly at higher doses or with prolonged use exceeding 3 months. It is a moderate inhibitor of CYP3A4 and CYP2C9 enzymes, meaning it can elevate plasma concentrations of anticoagulants such as warfarin, increasing bleeding risk, and may potentiate hypoglycemic agents including metformin and insulin. Panax ginseng demonstrates mild estrogenic activity via ginsenoside-mediated estrogen receptor binding, making it contraindicated or cautioned in individuals with hormone-sensitive conditions such as breast or uterine cancer. Pregnancy and breastfeeding use is not recommended due to insufficient safety data, and the ginsenoside ginsenoside Rb1 has shown teratogenic effects in animal models at high doses.